Skip to main content

Find Clinical Trials

Home
Conditions
Hemorrhage

Clinical trial condition

Hemorrhage

Explore clinical trials studying Hemorrhage. Study availability and eligibility vary by location and protocol.

210 public trials 19 recruiting studies

Refine in advanced search Browse all conditions

Hemorrhage trial results

Completed

Dose-ranging Study of Two Doses of Tranexamic Acid During Cardiac Surgery

NCT00809393

Conditions: Cardiopulmonary Bypass, Hemorrhage, Pathologic Processes, +1 more
Locations: department of anaesthesiology, CHU Jean Minjoz Besançon, France

department of anesthesiology, Haut Leveque Hospital Bordeaux, France

department of anesthesiology, Bichat Hospital Paris, France

Hopital Foch Suresnes, France

View Trial Details

Completed

Albumin vs. Plasma for PEdiAtric pRiming Trial

NCT02738190

Conditions: Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms
Locations: IRCCS San Donato San Donato Milanese, MI, Italy

View Trial Details

Completed

Non-Invasive Hemoglobin Monitoring in Patients With Hemorrhage

NCT01709786

Conditions: Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms
Locations: University Hospital Cincinnati, Ohio, United States

View Trial Details

Completed

The EVARREST® Fibrin Sealant Patch Liver Study

NCT01993888

Conditions: Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms
Locations: Clinical Investigation Site #13 Birmingham, Alabama, United States

Clinical Investigation Site #10 Augusta, Georgia, United States

Clinical Investigation Site #16 Chicago, Illinois, United States

Clinical Investigation Site #12 Chicago, Illinois, United States

View all 17 locations

View Trial Details

Completed

Management of Major Bleeding Events in Atrial Fibrillation Patients Using Pradaxa

NCT02149303

Conditions: Arrhythmias, Cardiac, Atrial Fibrillation, Cardiovascular Diseases, +4 more
Locations: 1160.200.02 Boehringer Ingelheim Investigational Site Boston, Massachusetts, United States

1160.200.06 Boehringer Ingelheim Investigational Site Boston, Massachusetts, United States

1160.200.01 Boehringer Ingelheim Investigational Site Brooklyn, New York, United States

1160.200.05 Boehringer Ingelheim Investigational Site Stony Brook, New York, United States

View Trial Details

Completed

Prevalence and Causes of Preventable and Serious Adverse Drug Reactions Related to the Use of Oral Anticoagulants

NCT02720328

Conditions: Cardiovascular Diseases, Embolism and Thrombosis, Hemorrhage, +3 more
Locations: Cliniques Universitaires Saint-Luc Brussels, Belgium

CHU UCL Namur site Godinne Yvoir, Belgium

View Trial Details

Completed

Safety, Tolerability, PK and PD of BI 655075 and Establishment of BI 655075 Dose(s) Effective to Reverse Prolongation of Blood Coagulation Time by Dabigatran

NCT01955720

Conditions: Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms
Locations: 1321.2.1 Boehringer Ingelheim Investigational Site Antwerp, Belgium

View Trial Details

Completed

Different Dose of Intravenous Omeprazole to Treat Bleeding Ulcer With Adherent Clot

NCT02536989

Conditions: Cardiovascular Diseases, Digestive System Diseases, Duodenal Diseases, +12 more
Locations: Far Eastern Memorial Hospital Taipei, Taiwan

View Trial Details

Completed

The Effect of Various External Pressure on Blood

NCT02520999

Conditions: Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms
Locations: Korea university anam hospital Seoul, South Korea

View Trial Details

Completed

TachoSil® Versus Surgicel® Original for the Secondary Treatment of Local Bleeding in Adult and Pediatric Patients Undergoing Hepatic Resection Surgery

NCT01192022

Conditions: Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms
Locations: Los Angeles, California, United States

Washington D.C., District of Columbia, United States

Chicago, Illinois, United States

Louisville, Kentucky, United States

View all 17 locations

View Trial Details